✦ LIBER ✦

Diphosphonate therapy in hypercalcemia of malignancy and tumoral osteolysis

✍ Scribed by J.-P. Bon; R. Rizzoli; A. Jung

Book ID: 119111448
Publisher: Elsevier Science
Year: 1984
Tongue: English
Weight: 405 KB
Volume: 5
Category: Article
ISSN: 0165-6147
DOI: 10.1016/0165-6147(84)90529-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale for diphosphonate therapy in h

Rationale for diphosphonate therapy in hypercalcemia of malignancy

✍ Robert E. Canfield 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 532 KB

Comparison of two parenteral diphosphona

Comparison of two parenteral diphosphonates in hypercalcemia of malignancy

✍ A. Jung 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 575 KB

Medical treatment of tumor-induced hyper

Medical treatment of tumor-induced hypercalcemia and tumor-induced osteolysis: challenges for future research

✍ J. J. Body 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 849 KB

Tumor-induced hypercalcemia (TIH) and tumor-induced osteolysis (TIO) are essentially due to a marked increase in osteoclast-mediated bone resorption. Parathyroid-hormone-like protein plays an essential role in TIH, and maybe in TIO, but other substances, such as growth factors or cytokines, could co

Mechanisms of hypercalcemia in malignanc

Mechanisms of hypercalcemia in malignancy

✍ Anatole Besarab; Jose F. Caro 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 995 KB

Prophylactic treatment of skeletal metas

Prophylactic treatment of skeletal metastases, tumor-induced osteolysis, and hypercalcemia in rats with the bisphosphonate Cl2MBP

✍ Burkhard Krempien; Christian Manegold 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 957 KB

Comparison of the two parenteral diphosp

Comparison of the two parenteral diphosphonates in hypercalcemia of malignancy: Jung A: Am J Med 1982; 72:221–226

📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 94 KB